S7

Stenocare A/SFRA Stenocare Stock Report

Last reporting period 30 Sep, 2023

Updated 22 Oct, 2024

Last price

Market cap $B

0.024

Micro

Exchange

XFRA - Deutsche Boerse AG

S7C.F Stock Analysis

S7

Uncovered

Stenocare A/S is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-49/100

Low score

Market cap $B

0.024

Dividend yield

Shares outstanding

11.421 B

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

View Section: Eyestock Rating